BFM
PFE icon

Boothbay Fund Management’s Pfizer PFE Stock Holding History

Boothbay Fund Management’s Portfolio PFE Stock Details PFE Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-94,600
Closed -$2.65M – 1849
2024
Q2 		$2.65M Buy
+94,600
New +$2.6M 0.06% 416
2023
Q2 		– Sell
-142,500
Closed -$5.81M – 2185
2023
Q1 		$5.81M Buy
+142,500
New +$6.15M 0.12% 207
2022
Q4 		– Sell
-20,300
Closed -$888K – 2352
2022
Q3 		$888K Buy
20,300
+5,500
+37% +$267K 0.02% 935
2022
Q2 		$776K Sell
14,800
-13,800
-48% -$703K 0.02% 944
2022
Q1 		$1.48M Sell
28,600
-1,305,800
-98% -$67.8M 0.03% 723
2021
Q4 		$78.8M Buy
+1,334,400
New +$66.1M 1.85% 4

Other funds holding PFE

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
State Farm Mutual Automobile Insurance
State Farm Mutual Automobile Insurance Bloomington, Illinois $127B AUM 32.55% 1-Year Est. Return

Boothbay Fund Management's PFE Position: Q1 2026 in Review

Boothbay Fund Management sold out of Pfizer (PFE) in Q1 2026, closing a stake of 12,127 shares — an estimated $302K sold.

Boothbay Fund Management first reported a position in PFE in Q4 2014 and held it in 18 quarters. The position peaked at $72.4M in Q4 2021. 2,936 funds tracked by Wall St. Rank hold PFE as of Q1 2026.

  • Boothbay Fund Management reported no remaining Pfizer position as of Q1 2026 after selling out during the quarter.
  • Boothbay Fund Management sold 12,127 Pfizer shares in Q1 2026, an estimated $302K.
  • Boothbay Fund Management first reported a position in Pfizer in Q4 2014 and held it in 18 quarters.
  • Boothbay Fund Management's Pfizer position peaked at $72.4M in Q4 2021.
  • 2,936 funds tracked by Wall St. Rank held Pfizer as of Q1 2026.

Based on Boothbay Fund Management's 13F filing for Q1 2026, filed 15 May 2026.